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ABSTRACT
THE ROLE OF THE NOVEL LUPUS ANTIGEN, ACHERON, IN MODERATING
LIFE AND DEATH DECISIONS
May 2014
ANKUR SHEEL B.S., UNIVERSITY OF MASSACHUSETTS AMHERST
B.S., UNIVERSITY OF MASSACHUSETTS AMHERST
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor Lawrence M. Schwartz
Programmed cell death (PCD) is a major regulatory mechanism employed during
development and homeostasis. The term PCD was coined to describe the death of the
intersegmental muscles (ISMs) of moths at the end of metamorphosis. The timing of ISM
death in the Tobacco Hawkmoth, Manduca sexta, is regulated by a fall in the titer of the
steroid molting hormone 20-hydroxyecdysone (20E) late on day 17 of pupal-adult
development. This triggers the release of the peptide hormone, Eclosion Hormone (EH),
which mediates its effects via the secondary messenger cGMP. It has been previously
demonstrated that ISM death requires de novo gene expression. One induced gene in the
ISMs encodes the novel protein Acheron. However, Acheron’s role in PCD is unknown.
Acheron is a novel member of the Lupus-Antigen family of RNA binding
proteins. In humans, Acheron is expressed in many tissues including the myoepithelial
cells in mammary ducts. Analysis of the mammary gland revealed that Acheron mRNA
levels were elevated in some basal-like breast cancers in women. Ectopic expression of
Acheron in human MDA-MB-231 breast cancer cells results in dramatic elevations in
proliferation, angiogenesis and metastasis. Moreover, Acheron expressing MDA-MB-231
cells in mouse xenographs resulted in tumors that were five times larger than control cell
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tumors. These data suggests that Acheron enhances the growth of some human breast
cancers.
This thesis describes two primary studies. The first tested the hypothesis that
Acheron functions as a survival protein for cells in vitro. MDA-MB-231 cells engineered
to express Acheron were challenged with various death-inducing treatments, which act
via different signaling pathways, to determine if Acheron expression confers survival.
Acheron protects cells from apoptosis induced by nutrient withdrawal, proteosome
inhibition, heat stress, mitochondrial toxins, inhibiting cellular respiration, DNA damage,
and oxidative stress. The second study tested the hypothesis that Acheron is
phosphorylated by a cGMP-dependent kinase in the ISMs when the cells initiate death
following adult eclosion. Using a non-radioactive in-vitro kinase assay I observed that
Acheron is phosphorylated via a cGMP-dependent kinase, presumed via kinase binding
motif predictions to be Protein Kinase G. Furthermore I show that phosphorylation is
coupled to Acheron degradation.
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CHAPTER I

INTRODUCTION

A Brief History of Developmental Biology
Scientists have sought answers to questions pertaining to embryonic development
since times of antiquity. During the fourth century BC, Aristotle recorded his
observations of embryos and stages during embryonic development to determine if
development was the result of preformationism or epigensis (National Research Council,
2000). As advances in technology gave rise to techniques such as microscopy, these
observational studies became more refined. It was not until the late 19th century that the
field of development really expanded. During 1880-1885, the first atlas of human
embryos titled “Anatomie Menschlicher Embryonen” was published by Wilhelm His.
This work was a collection of microscopic slides that was the first to map the
development of the kidney, limbs, central nervous system, heart and eyes in vertebrate
embryogenesis (National Research Council, 2000). Moreover it was during this time
period that the first instance of cell death was recorded by Karl Vogt during his
observations of amphibian metamorphosis (Vogt 1842).
The late 19th century was an era during which experimental biology was on the
rise and many systems were used to model development. In 1888 Wilhelm Roux
conducted a hallmark study using a two-cell stage frog embryo. Roux killed one of the
cells in this stage and observed that half an embryo developed. He concluded that cell
fate was determined at the two cell and four cell stage (Roux, 1888). Seven years later

1

this was refuted by the work of Hans Driesch, who repeated Roux’s experiments in sea
urchin embryos and showed that it was possible to remove portions from a developing
embryo without affecting the resulting organism (Driesch, 1895).
By the early 1900s techniques in experimental biology had advanced such that
they involved tissue removal. One of the hallmark studies in this era was the
transplantation experiment conducted by Hans Spemann and Hilde Mangold, in which
they published their discovery of the effect of “organizers” in the African clawed toad
Xenopus laevis (Spemann & Mangold, 1924). They described the organizer as a cluster
of cells that induces development of the central nervous system. Spemann won the 1935
Nobel Prize in Physiology or Medicine for this very discovery.
As techniques in cellular biology expanded, the next era in developmental biology
focused on changes at the cellular level (Horder, 2010). Specifically, many studies sought
to elucidate the role of the nucleus. Following his Nobel Prize, in 1938 Spemann
published another landmark paper demonstrating that the nucleus of a cell remains
totipotent after division (Spemann, 1938). By tying a piece of hair around a fertilized
salamander egg, Spemann separated the nucleus from other cellular components and
allowed the nuclear side of the constricted cell to divide until it reached the 16-cell stage.
He then allowed the second half of the restricted cell to divide by removing the hair and
allowing the nucleus to rejoin the other cellular components. The result of this
experiment was the birth of a twin set of salamanders.
This observation, along with the advances in nuclear transplantation techniques
by Robert Briggs and Thomas J. King (Briggs and King, 1952), catalyzed the famous
work of John Gurdon in 1962 in which he transplanted the nucleus from a fully
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differentiated intestinal epithelium cell of feeding tadpoles into a enucleated Xenopus
laevis egg to demonstrate that the nucleus contained the genetic information necessary to
allow for full development (Gurdon, 1962). The advances by Spemann, Briggs and King
and by Gurdon illustrated that developmental research began to focus more on
mechanisms that regulated development. One such mechanisms was cell death.

Cell Death
Cell death was first observed over 150 years ago by Karl Vogt (Vogt, 1842)
during his observations of amphibian metamorphosis, but it wasn’t until a review in 1951
by Glucksman that cell death returned as a focus of developmental research. In his
review, Glucksman “rediscovered” developmental cell death in embryological tissues by
observing that the core of the notochord disappears (Glucksman, 1951).
Glucksman’s review catalyzed many to pursue cell death, specifically Richard
Lockshin and Caroll Williams. Lockshin and Williams examined the disappearance of the
intersegmental muscles (ISMs), that was originally observed in 1935 (Kuwana, 1935) in
the Pernyi silkmoth following adult eclosion (emergence) at the end of metamorphosis.
The term Programmed Cell Death (PCD) was coined by Lockshin and Williams (1965) to
describe the temporally predictable death of these muscles. Since Lockshin’s studies, the
field of PCD has exploded: the Pubmed search engine lists more than 225,000 papers that
use the term “PCD” as a descriptor.
Today cell death is recognized to be a vital component of development and
homeostasis in unicellular organisms (Shemarova, 2010), vertebrates and invertebrates
(Ellis et al., 1991) and plants (Sergovia et al., 2003; Reape and McCabe, 2008).
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Numerous phenomena during mammalian development have been attributed to PCD. For
example, by using differential labelling of nuclei of human blastocysts in vitro Hardy et
al (1989) observed that a vast number of cells undergo cell death during development. In
vitro data from mouse embryos was used to show that cavitation of the proamniotic
cavity depends upon cell death of the inner ectodermal cells (Coucouvanis et al., 1995).
One classic example of cell death during development in humans is the disappearance of
the interdigital cells during the formation of the fingers (Lindsten et al., 2000). In
addition, cell death mechanisms are also involved in generating the four chambers of the
heart (Abdelwahid et al., 2002).
In 2002, H. Robert Horvitz received the Nobel Prize for Physiology or Medicine
for elucidating the genetic pathway for the most common form of PCD, apoptosis, in the
nematode Caenorhabditis elegans. Horvitz and colleagues identified mutations that
specifically enhanced or prevented PCD and developed a pathway implicating specific
genes in the process. In his work, Horvitz identified the first pro-apoptotic cell death
genes, ced-3 and ced-4 (Yuan et al., 1990). Later, he identified ced-9, a homolog of Bcl2, as a gene that protects cells from death (Hengartner et al., 1994). The conservation of
this pathway is so extreme, that human Bcl-2 can substitute for ced-9 in worms and
prevent cell death, despite more than 1.1 billion years of evolution (Vaux et al., 1992).

Markers of Death
Ultrastructural studies by Kerr, Wylie and Currie were the first to identify a
common set of morphological changes that occurred in dying cells: nuclear and
cytoplasmic condensation and fragmentation of the cell (Kerr et al., 1972), which they
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termed “apoptosis”. These morphological changes warranted more mechanistic
associated investigation. Consequently, today there are many molecular markers that are
associated with cell death.
One of the hallmarks of apoptotic cell death is the activation of endonucleases
that cleave genomic DNA at the inter-nucleosomal linker which generates the classic
“ladder” pattern on agarose gels therefore creating the classic ladder pattern that is seen
during electrophoresis (Williams et al., 1974; Wyllie, 1980).
In addition to nuclear changes, mitochondria undergo important changes during
cell death. Cytochrome c, which normally resides inside the inner membrane of the
mitochondria, is an important marker of death. In response to apoptotic stimuli,
mitochondrial membrane permeability increases and cytochrome c is released into the
cytosol where it binds Apaf-1 (Kroemer et al., 2007; Liu et al., 2004) and eventually
leads to activation and proteolytic cleavage of pro-caspase 3 (Zou et al., 1997). Caspase-3
then cleaves a variety of substrates within the cell that leads to the rapid demise of the
cell (Porter et al., 1999). For example, caspase-dependent cleavage of flippase allows the
phosphotidylserine to flip from the inner layer of the cell membrane to the outer layer,
where it acts as a signal for phagocytosis of the dying cell by macrophages and other cells
(Fadok et al., 1992).

Manduca sexta
One tool for gaining new insights into the control of PCD is to exploit an
invertebrate model system. In the Schwartz laboratory, we employ the tobacco
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hawkmoth Manduca sexta, a moth that is related to the silk moths studied by Lockshin.
In fact, many labs use the two species interchangeably.
Manduca require approximately 6 weeks to develop from an egg to an adult
during which time they grow approximately 10,000 fold. They begin life as a spherical
egg (diameter of 1.5 mm) deposited on a tobacco plant and hatch approximately 5 days
after they are laid. The larval form lasts approximately 20 days during which the animal
grows up to 70-80 mm in length. During the larval stage the animal spends the majority
of its time and energetic resources feeding on tobacco or tomato leaves. Mature larvae
wander away from the food source and burrow 10 to 15 cm into the ground where they
pupate. Manduca pupa are large and oval shaped and measure an average of 45 to 60 mm
in length. Under laboratory conditions, Manduca remain in their pupal state for 18 days
and the adult moth emerges late on day 18. Adult moths live for approximately 10 days
during which they allocate the majority of their energy and resources towards
reproduction.

PCD of Manduca ISMs
The ISMs of Manduca are formed in the embryo and are the major abdominal
muscles of the larva, pupa and pharate adult. They are divided into separate pairs of
bilaterally symmetric bundles. The ISMS are composed of striated skeletal muscle fibers
that are approximately 5 mm long and 1 mm diameter. During the larval stage, Manduca
use these muscles for locomotion whereas the pupa uses them for abdominal movement
during the eclosion behavior of the adult moth. The ISMs represent the major amino acid
stores required by the adult which are liberated when the cells undergo PCD (Schwartz,
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2008; Figure 1.1). In contrast to many experimental models of cell death that employ
chemical or physical insults to initiate cell death, the loss of the ISM is a normal
developmentally controlled process which offers a physiological means to the
endogenous mechanisms that regulate PCD.
Three days prior to eclosion, these muscle cells undergo normal hormonally
controlled atrophy during which the cells lose 40% of their muscle mass and 15-20% of
their volume (Schwartz and Truman, 1983). During this phase, there is no change in
resting potential or force per cross-sectional area (Schwartz and Ruff, 2002). However,
there is an increase in polyubiquitin mRNA expression and ubiquitin dependent
proteolysis which presumably facilitates protein turnover (Schwartz et al., 1990; Haas et
al., 1995).
ISM death occurs coincident with adult eclosion and is marked by the rapid loss
of mass (~ 4% per hour) and the resting potential (~ 2.5 mV per hour) (Schwartz and
Ruff, 2002). By 30 hrs post-eclosion, almost all the muscle mass is lost and all that
remains are whirls of connective tissue (Beaulaton and Lockshin, 1977). Muscles at day
15, day 18 and 13 hours post-eclosion are depicted in Figure 1.2.
Although these cells undergo PCD, they do not exhibit the classical signs of
apoptosis, as there is no membrane blebbing, DNA fragmentation or chromatin
condensation (Schwartz et al., 1993). Instead, these cells die via autophagy. They exhibit
membrane wrinkling, pyknosis and the retention of high molecular weight genomic
DNA/
The trigger for ISM PCD in the adult is a fall in the steroid molting hormone 20hydroxyecdysone (20E) late on day 17 of the pupal stage (Schwartz and Truman, 1983).
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The decline in 20E cause release of the peptide hormone Eclosion Hormone (EH) which
acts as the proximal trigger for death. Addition of exogenous 20E during the time of
eclosion blocks ISM PCD (Schwartz and Truman, 1984).
In 1969 Lockshin demonstrated that ISM PCD in silkmoths could be blocked by
inhibitors of RNA or protein synthesis (Lockshin, 1969) suggesting that death requires de
novo gene expression. The Schwartz lab demonstrated that this was true and using the
Manduca ISM model, they were the first group to clone death associated genes from any
system (Schwartz et al., 1990a). Some of these genes encoded previously characterized
proteins, including: polyubiquitin (Schwartz et al., 1990b); 20S and 26S proteasome
subunits (Jones et al., 1995; Sun et al., 1997), and apolipophorin III (Sun et al., 1995).
Others encoded novel proteins whose role in death and development was poorly
understood, such as: SCLP (Small Cytoplasmic Leucine Rich Repeat Protein) (Kuelzer et
al., 1999), DALP (Death Associated LIM-Only Protein) (Hu et al., 1999) and Acheron
(Valavanis et al., 2007).

Acheron
One of the novel genes that emerged from this screen encodes the protein
Acheron, a 55 kDa protein that is a member of the Lupus Antigen (LA) family of RNA
binding proteins (Valavanis et al., 2007). Northern blot analysis of Acheron mRNA
expression in the ISMs during various stages of pupal/adult development in Manduca
demonstrated that Acheron is expressed on day 18 of pupal development when the
muscles become committed to die. qPCR data shows an approximately 980 fold
induction of Acheron mRNA on day 18 of pupal development (Oppenheimer and
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Schwartz, unpublished). When animals are injected with the insect molting hormone 20hydroxyecdysone on the day preceding adult eclosion (day 17 of pupal-adult
development), both ISM death and the expression of Acheron are delayed (Valavanis et
al., 2007).
Immunohistochemical analysis of the ISMs demonstrated that Acheron localizes
to the presumptive M band in the muscles, suggesting that it is not freely dispersed within
the myoplasm. In agreement with this hypothesis, preliminary studies have shown that
Acheron is not soluble in low salt extraction buffer and instead pellets with the contractile
apparatus (Sheel, unpublished).
In addition to expression in the ISMs of Manduca, Acheron is also expressed in the
fruit fly Drosophila melanogaster. Microarray analysis during development in the fruit
fly Drosophila melanogaster has demonstrated that Acheron expression increases
dramatically just prior to adult eclosion, consistent with its expression in Manduca
(http://flybase.org/reports/FBgn0033936.html). Additional studies have demonstrated
that Acheron is preferentially expressed in pharate adult fly heads (unpublished). We are
yet to resolve if Acheron is expressed in the brain or the eclosion associated ptilinal
muscles (Laing, 1935).
Acheron is well conserved across phylogeny and shares high sequence identity
between insects and mammals, especially in certain domains (Valavanis et al., 2007). In
addition to an RNA binding motif, it also contains functional nuclear localization (NLS)
and nuclear export signals (NES) (Shao et al., 2012). Acheron binds to several proteins,
including CASK (Weng et al., 2009) and the ubiquitin E3 ligase Ariadne-1 (Wang et al.,
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2003). Acheron also binds to the 5’ untranslated region of the collagen I mRNA and
regulates both its subcellular localization and translatability (Cai et al., 2010).
In summary, several lines of evidence suggest that Acheron is a phylogenetically
conserved protein that may play key roles in normal development and pathogenesis. The
mechanisms by which Acheron mediates these effects have not been defined. The
purpose of this thesis is to elucidate the role Acheron plays in programmed cell death in a
mammalian model and to use this information to determine the role of Acheron during
PCD of the ISMs.
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Figure 1.1: ISM morphology in adult moths.
Morphology of the ISMs of a newly eclosed adult (a) and a 30 hour old adult (b) via light
microscopy. Solid headed arrows show the muscles in panel A, whereas 30 hours later
these muscles have disappeared. Scale bar is approximately 5 mm. Adapted from
Schwartz (2008).
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Day 15

Day 18 13 hrs PE

Figure 1.2 ISM morphology during pupal development
ISM morphology determined via light microscopy during pupal development on Day 15,
Day 18 and 13 hours post eclosion. Prior to day 18, there is a slight decrease in muscle
mass with very little change in cell number, however 13 hours after eclosion there is a
dramatic decrease in cell muscle mass.
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CHAPTER II

THE ROLE OF ACHERON IN DETERMINING CELL SURVIVAL

Introduction
The sudden and dramatic appearance of Acheron during day 18 of Manduca
pupal-adult development is intriguing. Specifically, why is the gene expressed when the
ISMs become committed to die at this stage? Perhaps Acheron is sensitizing the ISMSs
for death.
Several studies have attempted to elucidate the role of Acheron in other
invertebrate and vertebrate systems. One of the first studies investigating the function of
this protein demonstrated that Acheron played an essential role during differentiation in
myoblasts (Wang et al., 2009). Ectopic expression of Acheron in the mouse muscle
satellite cell line C2C12 resulted forced cells to either differentiate or die. It also drove the
expression of the myogenic regulatory factor, MyoD. Moreover upon differentiation from
myoblasts to multinucleated myotubes, Acheron expressing C2C12 cells formed larger
myotubes than did vector control cells. Taken together, the data suggested that Acheron
plays a role in driving muscle differentiation. In the same study, this hypothesis was
tested in vivo using zebrafish embryos. A reduction in Acheron expression, via antisense
morpholinos, led to a significant reduction in muscle fiber formation during
embryogenesis, while ectopic Acheron expression enhanced muscle fiber formation
(Wang et al., 2009).
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During myogenesis, differentiation cues are provided by interactions between
neighboring cells and the extracellular matrix. This interaction is mediated by
transmembrane proteins known as integrins (Boettiger et al., 1995). Studies in C2C12 cells
have explored the role of Acheron during the integrin-extracellular matrix interactions
required during myogenesis (Glenn et al., 2010). Control and Acheron-expressing
myoblasts each expressed the fibronectin receptor, composed of integrin subunits α5 and
β1, and the laminin receptor upon differentiation, composed of integrin subunits α7 and
β1. Inhibiting Acheron expression using antisense RNA or a dominant negative form of
the Acheron protein blocked expression of the laminin receptor. However, there was no
change in expression of the fibronectin receptor. Taken together the data suggested that
during differentiation Acheron may play a role in regulating cell adhesion and dynamics
(Glenn et al., 2010).
In a more recent study, the Schwartz laboratory demonstrated that Acheron is
expressed in several human tissues, including certain neurons, cardiac muscle, kidney,
skeletal muscle and mammary glands, specifically the myoepithilial cells. Relative to
normal mammary tissue in women, Acheron expression is elevated in some basal- like
breast cancers and suppressed in some non basal-like breast cancers (Shao et al., 2012).
MDA- MB-231 human breast cancer cells that were engineered to express ectopic
Acheron became more motile and expressed higher levels of VEGF (vascular endothelial
growth factor) and MMP-9 (Matrix metallopeptidase 9), two proteins associated with
metastasis. Consistent with these in vitro data, transplantation of Acheron-engineered
MDA-MB-231 human breast cancer cells into athymic mouse xenographs resulted in
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enhanced angiogenesis and tumors that were five times larger than those obtained with
vector control cells (Shao et al., 2012).
Previous studies of the Acheron in mammalian models indicate that Acheron
plays a role in differentiation and cell survival. The study by Shao et al. (2012), suggested
that Acheron enhances tumor growth. To test the hypothesis that Acheron enhances
tumor growth by functioning as a survival factor that protects cells from apoptosis, I
treated the Acheron expressing MDA-MD-231 cells, used by Shao et al., (2012), with
various toxic insults (Table 2.1). To mimic nutrient deprivation, I deprived the cells of
serum supplemented media. To induce proteosome inhibition, I treated the cells with
MG132. To induce oxidative stress I treated the cells with H2O2. To mimic heat stress, I
cultured the cells at 44oC for 20 minutes. To disrupt mitochondrial function, I treated
cells with Rotenone. To induce DNA damage, I treated the cells with the anti-cancer drug
camptothecin. In addition, I also disrupted cellular respiration by inhibiting oxidative
phosphorylation via carbonyl cyanide-3-chlorophenyl hydrazine (CCCP), a drug that
inactivates cellular respiration by interfering with ATP synthesis via uncoupling the
proton gradient that exists in the inner mitochondrial membrane. To determine if Acheron
was indeed protecting the cells from the above mentioned insults, survival was
determined using the XTT (2,3-Bis(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5carboxanilide inner salt) cell viability assay.
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Materials and Methods

Cell Culture
MDA-MB-231 cells expressing ectopic Acheron have been described previously
(Shao et al., 2012). Briefly, the human Acheron coding sequence was subcloned into the
pCMV-neo retroviral vector and MDA-MB-231 cells were transfected using Fugene 6
(Roche, Indianapolis, IN). In order to generate a stable cell line, cells were selected with
800 µg/mL G418 48 hours after transfection for a total of 2 weeks. Cells were cultured at
5% CO2 and 37°C in Dulbecco’s modified Eagle medium (DMEM) containing 10% Fetal
Bovine Serum (FBS) and penicillin/streptomycin.

Western Blot
Wildtype (WT), pCMV-Neo and pCMV-neo-Acheron cells were lysed in Lamelli
buffer and centrifuged at 10,000xg at 4oC for 8 minutes. The resulting supernatant were
boiled for 5 minutes and centrifuged for 1 min at 14,000xg at room temperature. 10 µg of
protein was loaded on a 12% SDS-PAGE (Bio-Rad) and was electrophoresed for 1 hour
at 150 volts at room temperature. Proteins were transferred to a PVDF membrane
(Millipore). Membrane was blocked in 5% nonfat dry milk in PBST and incubated with a
rabbit anti-Human Acheron antibody (1:100, Schwartz Laboratory). HRP labeled goat
anti-rabbit antisera (Bio-Rad, 1:3000) and an ECL kit (VWR) were used for detection.
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Cytotoxicity Assays
Cells were washed twice with warm phosphate buffered saline (PBS) and 1x105
cells were plated in a volume of 100µL per well in a Costar 96 well flat bottom plate
(Corning Life Sciences). Cells were allowed to adhere overnight and were then
challenged with various noxious treatments that would normally induce cell death. To
induce oxidative stress using hydrogen peroxide (H2O2), cells were grown in DMEM
lacking sodium pyruvate. For serum withdrawal, cells were incubated with DMEM
lacking FBS for the times indicated.
Cells were incubated with noxious treatments for 24 hours except in the case of
serum withdrawal, where cells were deprived of serum supplemented media for 6, 24 and
48 hours. MG132 (Sigma) was used at 0.25 µM, 0.5 µM, 1 µM and 2 µM. H2O2 (30%,
Fisher) was used at 2 µM, 4 µM, 6 µM and 8 µM. For heat induced death, cells were
cultured at 44oC for 20 minutes followed by 24 hour recovery. Rotenone (Sigma) was
used at 0.25 µM, 1 µM, 2.5 µM and 5 µM. Camptothecin (Sigma) was used at 100 nM,
200 nM, 300 nM and 400 nM. Carbonyl cyanide-3-chlorophenyl hydrazone (Sigma) was
used at 100 µM, 250 µM, 500 µM and 1000 µM.
Cell viability in the presence of noxious treatment was determined using XTT
(2,3-Bis(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide inner salt)
(Sigma) assay. Briefly, cells were cultured in the presence of the noxious agent for the
indicated times and then centrifuged for 3 minutes at 800rpm at 37oC. After
centrifugation, the media was removed and cells were resuspended in fresh growth media
containing XTT at a final concentration of 0.5mg/mL. To allow for the reduction of the
tetrazolium ring of XTT, cells were incubated at 5% CO2 and 37oC for 2 hours.
17

Absorbance values were determined at 490nM via the Flurostar Optima Plate reader. Cell
survival was determined by dividing the absorbance of the treated sample by the
absorbance of the sample treated with the appropriate vehicle control multiplied by 100
for a percentage value. Each plate had 8 replicates and each experiment was repeated at
least two times.

Statistics
Student’s two-tailed T tests were conducted using Microsoft Excel. Statistical
significance is denoted by asterisks (* indicates p<0.05, ** indicates p<0.01, ***
indicates p <0.005).
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Results
Western blot analysis of lysate from WT, pCMV-neo empty vector and pCMVneo-Acheron transfected MDA-MB-231 cells shows a strong band at 55kDa present in
only in the Acheron construct (Figure 2.1).
To test the hypothesis that ectopic expression of Acheron protected cells from
toxicity induced by nutrient starvation, I cultured cells in serum free media (Figure 2.2).
Acheron expressing cells deprived of serum for 6, 24 and 48 hours had an average
survival of 89.16% ± 6.59%, 88.96% ± 4.54% and 58.91% ± 2.54% respectively
compared to cells not deprived of serum. Vector control cells deprived of serum for 6, 24
and 48 hours had an average survival of 91.03% ± 5.19%, 52.99% ± 2.99%, and 45.82%
± 3.55% respectively. Acheron conferred protection to cells that had been deprived of
nutrients for 24 hours (p<0.005) and 48 hours (p<0.005).
Next, Acheron expressing and vector control cells were incubated for 24 hours in
the presence of the proteosome inhibitor, MG132 at concentrations of 0.25 µM, 0.5 µM,
1.0 µM, and 2.0 µM (Figure 2.3). Ectopic expression of Acheron protected cells from
toxicity induced by proteosome inhibition. Acheron expressing cells had average
survivals of 97.45% ± 3.69%, 89.75% ± 7.39%, 76.82% ± 6.81%, and 63.07% ± 7.31%
when exposed to 0.25 µM, 0.5 µM, 1.0 µM, and 2.0 µM MG132 respectively. Vector
control cells treated with 0.25 µM, 0.5 µM, 1.0 µM, and 2.0 µM MG132 had average
survivals of 66.37% ± 4.74%, 50.07% ± 3.92%, 39.53% ± 3.87% and 26.04% ± 3.28%
respectively. Acheron conferred protection to cells treated with 0.25 µM MG132
((p<0.005), 0.5 µM MG132 (p<0.005), 1.0 µM MG132 (p<0.005), and 2.0 µM MG132
(p<0.005).
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Next, oxidative stress was induced by treatment with H2O2 (Figure 2.4). Acheron
expressing cells treated with 2 mM, 4 mM, 6 mM and 8 mM H2O2 had average survivals
of 64.05% ± 3.26%, 39.69% ± 3.24%, 35.42% ± 2.54% and 33.57% ± 2.96% respectively
whereas vector control cells had average survivals of 94.46% ± 7.41%, 65.69% ± 7.77%,
63.94% ± 6.17%, 49.24% ± 4.82%. Ectopic expression of Acheron did not protect cells
from toxicity induced by oxidative stress.
Heat stress was tested next (Figure 2.5). Cells, normally cultured at 37oC, were
placed at 44oC for 20 minutes and then allowed to recover for 24 hours. Cells that
ectopically expressed Acheron had an average survival of 70.99% ± 3.44% compared to
unstressed Acheron expressing cells, whereas vector control cells had an average survival
of only 58.11% ± 3.28% compared to unstressed vector control cells. Overall, Acheron
conferred protection against heat stress (p<0.005).
To determine if Acheron protected against mitochondrial toxins, cells were
treated with rotenone (Figure 2.6). Acheron expressing cells treated with 0.25 µM, 1.0
µM, 2.5 µM and 5 µM Rotenone had average survivals of 80.58% ± 6.18%, 71.04% ±
5.49%, 23.31% ± 5.82% and 6.78% ± 2.14% respectively compared to untreated Acheron
expressing cells, whereas vector control cells had average survivals of 68.93% ± 6.07%,
47.87% ± 6.67%, 10.08% ± 2.52% and 2.66% ± 0.74% respectively compared to
untreated vector control cells. Acheron conferred protection for cells exposed to rotenone
concentrations of 1.0 µM (p<0.05) and 2.5 µM (p<0.005).
Next, cells were treated with the topoisomerase I inhibitor camptothecin, which is
used clinically as an anti-cancer therapeutic (Figure 2.7). Acheron expressing cells
treated with 100 nM, 200 nM, 300 nM and 400 nM camptothecin had average survivals
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of 100.01% ± 1.95%, 97.51% ± 3.59%, 79.01% ± 4.24% and 48.49% ± 5.05%
respectively compared to untreated Acheron expressing cells, whereas vector control
cells had average survivals of 80.33% ± 3.22%, 57.79% ± 7.91%, 53.75% ± 7.15% and
35.59% ± 8.52% respectively compared to untreated vector control cells. Acheron
conferred protection when exposed to camptothecin concentrations of 100 nM (p<0.005)
and 200 nM (p<0.005).
Finally, cells were treated with carbonyl cyanide-3-chlorophenyl hydrazone in
order to inhibit cellular respiration by blocking oxidative phosphorylation (Figure 2.8).
Acheron expressing cells treated with 100 µM, 250 µM, 500 µM and 1000 µM carbonyl
cyanide-3-chlorophenyl hydrazone had average survivals of 91.19% ± 3.85%, 72.33% ±
8.14%, 66.87% ± 6.31% and 23.33% ± 1.64% respectively compared to untreated
Acheron expressing cells, whereas vector control cells had average survivals of 69.74% ±
1.51%, 49.47% ± 5.64%, 36.98% ± 3.55% and 21.6% ± 2.71% respectively compared to
untreated vector control cells. Acheron conferred protection when exposed to carbonyl
cyanide-3-chlorophenyl hydrazone concentrations of 100 µM (p<0.005), 250 µM
(p<0.05), and 500 µM (p<0.005).
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Discussion
The purpose of this study was to test the hypothesis that Acheron functions, in
part, as a survival factor that can protect cells from a variety of insults. I utilized the
human breast cancer cell line MDA-MB-231 that had been engineered to ectopically
express Acheron. Both vector control and Acheron engineered cells were then
challenged with stressors that act on multiple pathways with cells and determine is the
cells could survive these insults.
The first insult I employed was nutrient withdrawal via serum starvation. In
MDA-MB-231 cells, the absence of nutrients due to serum starvation triggers cell cycle
arrest and death through a p53 independent mechanism (Jang et al., 2000). Ectopic
expression of Acheron protected cells from death after they were serum deprived for 24
hours and 48 hours (Figure 2.2).
The next class of toxins induced involved the buildup of misfolded and unfolded
proteins. MG132 is toxic to cells because it binds to the N-terminal threonine residue of
the β1 subunit of the 26S proteosome and blocks proteolysis (Myung et al., 2001). This
results in a buildup of toxic levels of unfolded and misfolded proteins in the cell
(Sherman and Goldberg, 2011). Of all the toxic stimuli tested in this study, ectopic
expression of Acheron conferred the greatest degree of protection against MG132
toxicity (Figure 2.3). In line with toxicity due to unfolded and misfolded proteins, the
cells were also subjected to heat stress since elevating the temperature increases in the
amount of misfolded and unfolded proteins in cancer cells (Jolly and Morimoto, 2000).
Similar to MG132, ectopic expression of Acheron protected cells against toxicity due to
heat stress (Figure 2.5). Taken together, the data from Figure 2.3 and Figure 2.5 suggests
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that Acheron protects cells that are challenged with stress associated with misfolded and
unfolded proteins.
Many cells are subjected to oxidative stress due to transient increases in levels of
reactive oxygen species (ROS). Oxidative stress can be caused by a variety of
endogenous and exogenous factors such as cellular senescence (Hagen et al., 1997),
changes in levels of certain growth factors (Yu et al., 2006), and environmental factors
such as UV radiation (Zhang et al., 1997). In order to determine if Acheron protects cells
from ROS damage, I treated cells with H2O2. Acheron did not confer any protection
against H2O2 treatment- in fact Acheron expression sensitized the cells to death as
survival in control cells was significantly greater (Figure 2.4).
The fact that Acheron sensitized cells to hydrogen peroxide induced toxicity
warranted further investigation. Hydrogen peroxide can induce cell death via two
different mechanisms: apoptosis (Cerella et al., 2009) and necrosis (Miyoshi et al., 2006).
The process of death induced during these two pathways are drastically different.
Structurally, cells undergoing necrosis lose cell membrane integrity, swell and ultimately
rupture thereby releasing their cellular contents whereas cells undergoing apoptosis
maintain membrane integrity, shrink and generally do not rupture. Moreover at the
nuclear level, cells undergoing necrosis have random degradation of DNA whereas cells
undergoing apoptosis undergo chromatin condensation and non-random fragmentation of
DNA.
Studies in human T-lymphoma Jurkat cells have shown that the mechanism of
hydrogen peroxide induced death (apoptosis or necrosis) is dependent on concentration
and time of exposure (Saito et al., 2006). Furthermore, studies treat MDA-MB-231 with
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3mM hydrogen peroxide as a positive control for necrosis (Galluzzi et al., 2012). Given
the concentration of hydrogen peroxide used in this study, the data from Figure 2.4
indicated that Acheron does not protect cells from necrosis triggered cell death. Perhaps
Acheron mediates its necrosis effect through increased integrin expression, as necrosis is
often observed with increased expression of α and β integrins (Bachmann et al., 2008).
However, the question if Acheron protected against ROS induced apoptosis remained.
Given that cell death was not induced in these cells unless the concentration of
hydrogen peroxide was greater than 2mM for 24 hours, the data from Figure 2.4 suggest
that ROS-induced apoptosis in MDA-MB-231 cells could not be achieved via hydrogen
peroxide. Therefore toxicity due to rotenone was tested. Rotenone inhibits transfer of
electrons from the iron-sulfur centers in the mitochondrial respiratory chain complex I to
ubiquinone, which leads to elevated ROS production and cell death via apoptosis (Li et
al., 2003). Ectopic Acheron expression did protect cells from rotenone toxicity (Figure
2.6).
In order to determine if Acheron mediates its effect with toxicities associated with
mitochondria, cells were exposed to carbonyl cyanide-3-chlorophenyl hydrazine
(CCCH). CCCH is an inhibitor of cellular metabolism as it interferes with oxidative
phosphorylation during the electron transport chain by inhibiting cytochrome c oxidase
(Tsyrlov et al., 1976). Acheron conferred protection against CCCH (Figure 2.8)
indicating that it protected against mitochondrial associated toxicities.
Finally, given that Acheron has a functional NLS and NES and the DNA binding
winged helix-turn-helix domain (Brennan et al., 1989), I tested the hypothesis that
Acheron protected against DNA damage by treating cells with camptothecin.
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Camptothecin induces DNA damage by blocking the re-ligation step of the cleavage
reaction of topoisomerase I during S-phase of the cell cycle (Liu et al., 2000). Indeed
Acheron protected against toxicity due to camptothecin (Figure 2.7). One interpretation
of this data is that Acheron may translocate into the nucleus and possibly utilize its
winged helix-turn-helix domain in order to bind DNA thereby shielding it from the
fragmentation that is typically observed during. However, this may not be the case since
ISM death is not associated with fragmentation of DNA (Schwartz et al., 1993).
Basal-like breast cancers are more aggressive and are typically associated with
poor prognosis compared to non basal-like breast cancers (Rakha et al., 2008). Shao et
al., (2012) demonstrated that basal-like breast cancers have greater levels of Acheron
mRNA, and that xenographed human tumors that ectopically expressed Acheron had
higher rates of proliferation and angiogenesis suggesting that Acheron enhanced tumor
growth.
The data in this study suggests that Acheron may be enhancing tumor growth, in
part, by protecting cells from death via apoptosis. One interpretation of these data is that
tumors that express Acheron, such as basal-like breast cancers, may be less sensitive to
chemotherapeutic intervention. Studies have shown that invasive breast cancer tumors
also have high expression of Laminin-332 (Kim et al., 2012), which plays an important
role in conferring cell migration and survival by binding to integrins composed of α3β1
subunits (Zahir et al., 2003). Given that inhibiting Acheron expression results in no
expression of the Laminin receptor, composed of α7β1 subunits, another interpretation of
the data is that Acheron promotes tumor growth through regulation of the Laminin
receptor-perhaps Acheron mediates its effect in breast cancers through the β1 subunit.
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Future studies need to be conducted in order to further investigate the mechanism
of Acheron action. Figure 2.1 shows that MDA-MB-231 cells do not natively express
Acheron, therefore a more appropriate study would be to repeat the cytotoxicity
experiments from this chapter using a cell line in which endogenous Acheron expression
has been silenced. Furthermore, this proposed study will have more mechanistic
relevance if these studies were done in the Manduca GV1 cell line as these arise from
Manduca embryos and natively express Acheron (Sheel, unpublished).
Furthermore the Acheron gene used in this study was fused to a HA epitope tag at
the N-terminus of Acheron via PCR (Shao et al., 2012). Using an anti-HA antibody, coimmunoprecipitation (co-IP) of Acheron in the MDA-MB-231 cells can be used to
precipitate Acheron while in a complex with its binding partners. The Acheron
complexes can then be separated via SDS-PAGE and the resulting proteins can then be
identified via Mass Spectroscopy. Utilizing this approach, we can identify binding
partners and possibly elucidate the biochemical pathways that mediate Acheron action.
The role of Acheron in the ISMs can be further elucidated using the data from this
chapter. Given that Acheron protects MDA-MB-231 cells from death inducing toxicities,
the initial predication that Acheron sensitizes the ISMs for death is likely incorrect. In the
ISMs, one possible role for Acheron is that it serves to protect the cells from endogenous
death-inducing factors until the actual initiation of death, and then it becomes modified,
sequestered and/or lost just prior to the actual initiation of PCD.
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Table 2.1: Stressors used in MDA-MB-231 cytotoxicity assays
Class

Reagent

Range Used

Nutrient Withdrawal

Serum Starvation

0 to 48 hours

Proteosome Inhibition

MG132

0.25 µM to 2 µM

Oxidative Stress

H2O2

2 µM to 8 µM

Heat Shock

Increased Temperature

44oC

Mitochondrial toxin

Rotenone

0.25 µM to 5 µM

DNA Damage

Camptothecin

0.25 µM to 5 µM

Inhibition of cellular
respiration

Carbonyl Cyanide-3Chlorophenyl Hydrazone

100 µM to 1000 µM
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Figure 2.1: Acheron expression in MDA
MDA-MB-231
231 cells used in cytotoxicity assays
MDA-MB-231
231 cells were transfected with pCMV
pCMV-Neo
Neo empty vector or pCMV-NeopCMV
Acheron and antibiotic selected. Cells were lysed and expression of Acheron was
determined in wild type cells, pCMV
pCMV-Neo transfected cells and pCMV-Neo
Neo-Acheron
transfected cells.
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Figure 2.2: Effect of Acheron on Nutrient Withdrawal Induced Toxicity
Percent viabilities for Acheron expressing or Vector Control MDA
MDA-MB-231
231 cells
following serum starvation for 6, 24 and 48 hours. Data was pooled from 3 independent
experiment of which each had at least 8 replicates. Error bars represent ± S.E.M.
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Figure 2.3: Effect of Acheron on Proteosome Inhibition Induced Toxicity.
Toxicity
Percent viabilities for Acheron expressing or Vector Control MDA
MDA-MB-231
231 cells
following treatment with MG132 at 0.25 µM, 0.5 µM, 1 µM and 2 µM. Data was pooled
from 2 independent experiment of which each had at least 8 replicates. Error bars
represent ± S.E.M.
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Figure 2.4: Effect of Acheron on Oxidative Stress Induced Toxicity.
Percent viabilities for Acheron expressing or vector control MDA-MB-231
231 cells
following treatment with H2O2 at 2 mM, 4 mM, 6 mM and 8 mM. Data was pooled from
3 independent experiment of which each had at least 8 replicates. Error bars represent ±
S.E.M.
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Figure 2.5: Effect of Acheron on Heat Stress Induced Toxicity.
Percent viabilities for Acheron expressing or vector control MDA-MB-231
231 cells
o
following treatment at 44 C for 20 minutes. Data was pooled from 2 independent
experiment of which each had at least 220 replicates. Error bars represent ± S.E.M.
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Figure 2.6: Effect of Acheron on Rotenone Induced Toxicity.
Percent viabilities for Acheron expressing or vector control MDA-MB-231
231 cells
following treatment with Rotenone at 0.5 µM, 1.0 µM, 2.5 µM and 5.0 µM. Data was
pooled from 2 independent experiment of which each had at least 8 replicates. Error bars
represent ± S.E.M.
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Figure 2.7: Effect of Acheron on DNA Damage Induced Toxicity.
Percent viabilities for Acheron expressing or vector control MDA-MB-231
231 cells
following treatment with Camptothecin at 100 nM
nM,, 200 nM, 300nM, and 400 nM. Data
was pooled from 2 independent experiment of which each had at least 8 replicates. Error
bars represent ± S.E.M.
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Figure 2.8: Effect of Acheron on Inhibition of Cellular Respiration Induced
nduced
Toxicity.
Percent viabilities for Acheron expressing or Vector Control MDA
MDA-MB-231
231 cells
following treatment with carbonyl cyanide-3-chlorophenyl hydrazone at 100 µM, 250
µM, 500 µM and 1000 µM. Data was pooled from 2 independent experiment of which
each had at least 8 replicates. Error bars represent ± S.E.M.
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CHAPTER III
DEGREDATION OF ACHERON VIA A cGMP MECHANISM

Introduction
In 1971 Earl Sutherland proposed the Second Messenger hypothesis in which he
set forth four criteria that need to be fulfilled in order to identify a cyclic nucleotide as a
second messenger that mediates the action of a given hormone (Sutherland and Robison,
1966). First, the cell must synthesize the cyclic nucleotide in response to the hormone.
Second, exogenous addition of the hormone must trigger synthesize of the cyclic
nucleotide in a dose and time dependent manner. Third, drugs that inhibit
phosphodiesterase should mimic the action of the hormone. Finally, the fourth criteria of
this hypothesis was that addition of exogenous cyclic nucleotide should mimic the action
of the hormone.
Studies in the silkmoth Antheraea polyphemus have demonstrated that EH
induces the expression cyclic GMP as a second messenger, and this in turn activates the
death machinery within the cell (Schwartz et al., 1984). However, the downstream steps
that couple hormone action to the endogenous “death program” have yet to be identified.
The study by Schwartz et al., (1984) was novel in that it was one of the first publication
to fulfill all four of Sutherland’s criteria in order to establish that cGMP is a second
messenger in any system.
Western blot analysis has shown that Acheron expression is induced late on day
17 of pupal-adult development when the ISMs become committed to die late on day 18.
(“Committed” in this context means that the addition of exogenous 20E will no longer
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delay the timing of death). The Acheron protein is present in the ISMs throughout all of
day 18 and then is dramatically and specifically lost from the cells during the few
minutes before adult eclosion and the activation of the death machinery (Brown and
Schwartz, unpublished). One interpretation of this expression data is that Acheron
actually serves as a survival protein that protects the ISMs from the action of the death
machinery. When Acheron is then lost, the death program becomes de-repressed and
serves to kill the cell, making Acheron the proximal trigger for the initiation of death.
Since EH triggers cGMP, which works via protein kinases that phosphorylate
specific protein substrates, the Schwartz lab began testing the hypothesis that Acheron
may be phosphorylated in the ISMs. Western blotting with anti-phospho serine/threonine
antibody has demonstrated that Acheron is labeled in condemned ISMs (Smith, Brown
and Schwartz, unpublished), suggesting that it may be subject to regulation in a cGMP
manner.
In this chapter I use in vitro cell-free ISMs extracts and a novel non-radioactive
kinase assay to provide evidence that Acheron is phosphorylated in a cGMP dependent
manner and that this phosphorylation triggers Acheron degradation.
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Materials and Methods
DNA Constructs
ISMs from day 18 animals were dissected at various times relative to adult
eclosion, snap frozen on dry ice and stored in liquid nitrogen until used. RNA was
isolated via RNeasy Mini Kit (Qiagen) and cDNA was synthesized using the SuperScript
III First-Strand Synthesis System (Invitrogen) per manufacturer’s instructions. The
following primers were used to amplify the Acheron ORF from the synthesized cDNA:
For: 5’ TATTGCGTGAATGCGCGCGC 3’
Rev: 5’ TCGAACACCGCCACAGCGT 3’
The PCR product was cloned into the pCR2.1-TOPO vector via the TOPO TA Cloning
kit (Invitrogen) to create pCR2.1-TOPO-M44a. pCR2.1.TOPO-M44a was digested with
EcoRI and the Acheron ORF was subcloned into the EcoRI site of the pMT/V5-HisB
vector such that Acheron expression was under control of the metallothionine promoter
(Bunch et al., 1988). The pMT/V5-HisB vector was a generous gift from Dr. Tom
Maresca.
Cell Culture
Drosophila S2 cells were cultured at 28oC in S2 insect media containing 10%
FBS, penicillin (50 units/mL) and streptomycin (50µg/mL). S2 cells were transfected
with the pMT/V5-HisB-M44a construct in a 6-well plate using Effectene (Qiagen)
according to manufacturer’s instructions. 24 hours post transfection, cells were antibiotic
bulk selected with 25µg/mL Blasticidin (Life Technologies) for 2 weeks. Stable
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expression of ectopic protein was determined by Western blotting using rabbit an antiAcheron antiserum (1:200, Schwartz laboratory).
Preparation of Intersegmental Muscle Extracts
ISMs were isolated from animals at various time on day 18, including 1 hr posteclosion (PE). The tissues were snap frozen on dry ice and stored in liquid nitrogen until
used for assays. Strips of ISM tissue from individual animals (two strips of four
segments each) were pulverized in liquid nitrogen via mortar and pestle, and then
homogenized using a Type B Dounce Homogenizer at 4oC in phosphate buffered saline
(137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4 and 2 mM KH2PO4) supplemented with
cOmplete protease inhibitor (Roche) and PhosStop phosphatase inhibitor (Roche) in
order to create a broken cell prep (BCP).
Kinase Assay
5 µL D18 ISM BCP or S2 extract was combined with 5 µL 1 hour PE extract or 5
µL D18 ISM BCP and 5 µL of Reaction Mixture (30 mM MgCl2, 1.5 mM DTT, 75 mM
β-glycerophosphate, pH 7.3, 0.15 mM sodium orthovanadate, 3.75 mM EGTA and 0.3
mM ATP). 8-Bromo-cGMP, sodium salt (8-bromoguanosine cyclic 3',5'-monophosphate
sodium salt) (Tocris Bioscience) was added to a final concentration of 10mM. IBMX
(3,7-Dihydro-1-methyl-3-(2-methylpropyl)-1H-purine-2,6-dione) (Tocris Bioscience)
was added to final concentration of 10µM. The resulting mixture was incubated at room
temperature for 20 minutes and then the reaction was stopped by adding an equal volume
of Sample Buffer (Bio-Rad).
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Western Blot Analysis
Samples were boiled for 5 minutes and centrifuged for 1 min at 14,000xg at room
temperature. Samples were loaded on a 12% SDS-PAGE (Bio-Rad) and were
electrophoresed for 1 hour at 150 volts at room temperature. Proteins were transferred to
a PVDF membrane (Millipore). Membrane was blocked in 5% nonfat dry milk in PBST
and incubated with a rabbit anti-Manduca Acheron antibody (1:200, Schwartz
Laboratory). HRP labeled goat anti-rabbit antisera (Bio-Rad, 1:3000) and an ECL kit
(VWR) were used for detection.
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Results
ISMs from the day 18 pupal stage of Manduca shows that Acheron, visualized by
a strong band at 55kDa, is solubilized in the presence of Laemmli buffer as well as in the
PBS BCP (Figure 3.1). However, in the absence of the phosphodiesterase inhibitor
IBMX, neither the addition of 8-bromo-cGMP nor addition of ATP triggers a shift in
molecular weight of Acheron (Figure 3.1).
Addition of IBMX resulted in an upward shift of the Acheron band on the gel,
marked by a black arrow. This sample is noted as D18-P. As can be seen in the figure,
this shift corresponds to an increase in molecular weight compared to both endogenous
Acheron in the D18 BCP and Acheron ectopically expressed by Drosophila S2 cells
(Figure 3.2). Figure 3.2 also shows that the higher molecular weight Acheron band
disappears upon addition of extract from ISMs 1hr PE. However, the modified Acheron
band remains when the 1hr PE extract is added in the presence of Laemmli buffer (Figure
3.2).
Degradation of Acheron was only observed after cGMP and IBMX had been
added to the day 18 BCP (Figure 3.3). As observed before, addition of the 1 hr PE extract
resulted in disappearance of the Acheron band seen in the D18-P Acheron sample,
whereas the Acheron band was still present when the D18-P sample was added to the 1 hr
PE extract in the presence of Laemmli buffer to arrest any biochemical reactions.
However addition of D18 extract, without cGMP and IBMX, to the 1 Hr PE extract did
not result in disappearance of the Acheron band (Figure 3.3).
I next engineered Drosophila S2 cells to express Manduca Acheron and used that
as a source of Acheron that would lack the machinery for its eclosion associated
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degradation. The stability of the exogenous Acheron appeared to be regulated similarly
to endogenous ISM Acheron. A band at 55 kDa corresponding to Acheron from S2
extract could be visualized by Western blotting. Upon addition of the D18 extract along
with cGMP and IBMX, a thicker band with a slightly higher molecular weight than
native Acheron was observed (Figure 3.4). However when extract from the 1 hr PE
sample was added, there was a dramatic reduction in the intensity of this band (Figure
3.4).
Our hypothesis is that cGMP dependent kinase phosphorylates Acheron in a
sequence-specific manner. As a first step to test this hypothesis, I aligned the Acheron
protein sequences from Manduca sexta, Drosophila melanogaster, Mus musculus, Danio
rerio, and Homo sapiens to look for phylogenetically conserved serine residues and
threonine residue (Figure 3.5). I observed 7 conserved serine residues at residues 84,
107, 112, 113, 135, 163 and 284 and one conserved threonine at residue 121 in the
Manduca sexta Acheron coding sequence. Further motif analysis revealed that the Ser
163 residue was a potential PKG binding site (Figure 3.5).
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Discussion
Given that death of the ISMs is dependent on cGMP as a second messenger, the
purpose of this study was to test the hypothesis that Acheron degradation is mediated by
a cGMP-dependent mechanism. In order to test this hypothesis, ISMs were isolated from
animals at two developmental stages: pre-eclosion day 18and 1 hr PE. The pre-eclosion
ISMs contain endogenous Acheron which is missing an hour later. ISMs were
homogenized in PBS buffer to create a broken bell preparation (BCP) that should contain
both Acheron and the enzymatic machinery that modifies the protein.
As seen in Figure 3.1, there is no shift in molecular weight of Acheron upon the
addition of either cGMP or ATP in the absence of the phosphodiesterase inhibitor IBMX.
However upon addition of both IBMX and cGMP, there is an increase in molecular
weight of Acheron (Figure 3.2). Based on the pattern of the shift, and separate studies
that demonstrate the presence of phosphor-ser/thr (Smith, Brown and Schwartz,
unpublished) this shift in molecular weight is presumed to represent a phosphorylation
event. The fact that the presumptive phosphorylation was dependent on the addition of
the phosphodiesterase provides further support for the fact that this is likely a cGMP
mediated process.
Furthermore, the presumptive phosphorylated Acheron is degraded upon addition
of the 1 hr PE extract (Figure 3.2). This indicates that the enzymes and proteases required
to degrade Acheron are present and active in the 1 hr PE extract but not in the D18
extract. These data are consistent with previous Western data demonstrating that
Acheron is present on day 18 but the degraded just prior to adult eclosion and absent
post-eclosion.
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Phosphorylation of Acheron appears to be required for its degradation (Figure
3.3). Figure 3.3 shows that when D18 extract, which contains native Acheron, is mixed
with 1 hr PE ISM extract, Acheron protein is retained. However, if the same experiment
is performed in the presence of the phosphodiesterase inhibitor IBMX plus cGMP, then
Acheron is degraded. These data support the hypothesis that Acheron phosphorylation is
required for degradation by enzymes present in the 1 hr PE extract. Finally, exogenously
synthesized Acheron can also be phosphorylated using the kinases and enzymes present
in the D18 extract and then degraded after phosphorylation by the 1 hr PE extract (Figure
3.4).
One interesting point to emphasize, is that these assays were conducted in the
presence of Roche’s cOmplete protease inhibitor. Therefore, the degradation of Acheron
was facilitated by an enzyme or protease that was insensitive to this broad series of
inhibitors. In theory, this means that the eclosion associated degradation of Acheron is
not mediated by the serine proteases trypsin and chymotrypsin, the cysteine protease
papain, and the metallo-protease thermolysin (Roche). Therefore the “Acheronase”
pathway utilizes different enzymatic machinery or the protease inhibitors present in this
cocktail are not very active against the endogenous Manduca proteases used to degrade
Acheron.
Given that phosphorylation occurs on serine, threonine and tyrosine residues, in
order to further validate that Acheron can be phosphorylated, I aligned the Acheron
sequences from Manduca sexta, Drosophila melanogaster, Mus musculus, Danio rerio,
and Homo sapiens. The alignment revealed that there are seven evolutionary conserved
serine residues and one evolutionary conserved threonine residue in the full length

44

Manduca sequence (Figure 3.6). Given that cGMP mediates its effects through Protein
Kinase G (PKG), analysis of kinase binding motifs of these conserved phosphorylation
residues, revealed Ser 163 as a possible PKG binding site (Figure 3.6). Taken together,
the data in this chapter suggests that the dramatic disappearance of Acheron on Day 18 of
development is due to phosphorylation via a cGMP mediated mechanism, possibly on Ser
163.
To further emphasize that this shift corresponds to phosphorylation and not
acetylation, methylation or another post translational modification, these kinase assays
need to be repeated using purified Acheron, purified PKG and radioactive 32P. Further
studies can also be conducted using the above mentioned kinase assays on Acheron
versions in which the presumed serine residue is mutated to a phospho-null variant, such
as alanine (Pearlman et al., 2011), or to a phospho-mimic residue such as glutamate or
aspartate (Pearlman et al., 2011) in order to determine if Acheron can be degraded.
In Chapter II, I provided evidence that Acheron could possibly function by
protecting cells. Given the dramatic disappearance of Acheron immediately preceding
ISM death one possible explanation is that Acheron is protecting the ISMs from death.
Taken together with the fact that ISM death in Manduca occurs via a cGMP-dependent
mechanism, the evidence from this chapter suggests that cGMP is responsible for
triggering the phosphorylation and subsequent degradation of Acheron by Acheron
specific degradation enzymes present 1 Hr post eclosion.
Moreover, the data presented here are consistent with the hypothesis that loss of
Acheron triggers ISM death. A proposed model for the eclosion hormone dependent
degredation of Acheron and subsequent death of the ISMs is depicted in Figure 3.6. This
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hypothesis is being tested directly using Acheron RNAi in Drosophila (Johnson, Sheel,
Markstein and Schwartz, unpublished). Additional studies are focused on performing coimmunoprecipitation of Acheron from day 18 ISMs to identify presumptive Acheron
binding partners. This might help delineate the mechanism by which Acheron may
inhibit PCD.
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Figure 3.1: Acheron modification in the absence of the phosphodiesterase inhibitor
IBMX
Analysis of Acheron in expression in D18 ISMs with anti-Manduca Acheron via Western
blotting. The first lane (D18
(D18-Laemmli) contains lysate from D18 extracted in Laemmli
buffer.. The second lane (D18
(D18-BCP) contains the D18 PBS broken cell prep.
prep The third
lane (D18+cGMP) contains the products of the kinase reaction with D18 PBS broken cell
prep and exogenous cGMP in the absence of IBMX. The fourth lane (D18+ATP)
contains the products of the kinase reaction with D18 PBS broken cell
ell prep, exogenous
cGMP and ATP in the absence of IBMX. The bands corresponding to Acheron is denoted
denot
by a black arrow.
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Figure 3.2: Endogenous Acheron Modification and Degradation
Analysis of Acheron after the kinase assay using D18 ISMs detected
etected with anti-Manduca
anti
Acheron via Western blotting
blotting. The first lane (D18 BCP) contains the D18 PBS broken
cell prep.. The second lane (S2 Ext) contains the extract from Drosophila S2 cells
engineered to express ectopic Manduca Acheron. The third lane (D18-P)
P) contains the
products of the kinase assay using the D18 PBS broken cell prep with exogenous cGMP
and IBMX.. The fourth lane (1Hr + D18
D18-P)
P) contains the products of the reaction when
BCP from ISMs staged at 1hr PE is added to the D18-P sample. The fifth lane (1Hr +
D18-P in Laemmli) contains the products of the reaction when BCP from ISMs staged at
1hr PE is added to the D18
D18-P sample in the presence of Laemmli buffer. The presence of
the modified Acheron is denoted by a black arrow.
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Figure 3.3: Presumptive Phosphorylation
orylation of native Acheron is required for
degradation
Analysis of Acheron after the kinase assay using D18 ISMs detected with anti-Manduca
anti
Acheron via Western blotti
blotting. The first lane (D18-P)
P) contains the products of the kinase
assay using the D18 PBS broken cell prep with exogenous cGMP and IBMX. The second
lane (1Hr + D18-P)
P) contains tthe
he products of the reaction when BCP from ISMs staged at
1hr PE is added to the D18
D18-P sample. The absence of Acheron protein is marked by an
arrow. The third lane (1Hr + D18
D18-P in Laemmli) contains the products of the reaction
when BCP from ISMs staged at 1hr PE is added to the D18-P
P sample in the presence
presen of
Laemmli buffer. The fourth lane (1hr + D18 in Laemmli) contains the products of the
reaction when BCP from ISMs staged at 1hr PE is added to the BCP from D18 in the
presence
ce of Laemmli buffer. The fifth lane (1hr + D18) contains the products of the
reaction when BCP from ISMs staged at 1hr PE
E is added to the BCP from D18.
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Figure 3.4: Ectopic Acheron can be modified and degraded.
Analysis of Acheron synthesized ectopically in S2 cells detected with anti-Manduca
anti
Acheron via Western blotting
blotting. The first lane (S2 Ext) contains the extract from the S2
cells. The second lane (S2
(S2-P) contains the products of the reaction when Day 18 ISM was
added to the S2 Ext sample along with cGMP and IBMX. The presence of the modified
Acheron is denoted by a black arrow. The third lane (1Hr+S2-P) contains the products
of the reaction
ction when extract from ISMs staged at 1 hr PE is added to the S2-P
S2 sample.
The absence of the modified Acheron is denoted by a bblack arrow.
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Figure 3.5: Acheron protein se
sequence alignment
Alignment of the Acheron protein sequence for Manduca sexta, Drosophila
melanogaster, Mus musculus, Danio rerio and Homo sapien with conserved Serine and
Threonine residuess highlighted in green and the potential PKG phosphorylation site
boxed in red.
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Figure 3.6: Proposed Model of Acheron’s Role in ISM Cell Death.
Proposed model of ISM death. The decline in 20E triggers the release of Eclosion
Hormone. Eclosion hormone binds to its receptors and causes a release in cGMP.
Activation of cGMP presumably activates PKG which phosphorylates Acheron.
Presumptive phosphorylation
phorylation of Acheron targets it for degradation via Acheron specific
machinery present 1 Hr P.E. Finally, loss
oss of Acheron triggers cell death.
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